Basic info
Industry
biotechnology research
Sectors
Eye Health
Glaucoma
Biotechnology
ocular surface disease
Therapeutics
Presbyopia
AMD
Optometry
dry eye disease
Ophthalmology
macular degeneration
Date founded
2019
Funding rounds raised
Total raised
$36M
from 2 investors over 2 rounds
V
Visus Therapeutics, Inc. raised $20M on August 10, 2021
Investors: EQT Life Sciences
V
Visus Therapeutics, Inc. raised $36M on March 9, 2021
Investors: RTW Investments, LP